Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12623000523606
ACTRN12623000523606
Recruiting
未知

nderstanding Biomechanical and Functional Outcomes in Primary and Revision Total Hip Arthroplasty Patients

Royal Adelaide Hospital, Central Adelaide Local Health Network0 sites130 target enrollmentMay 19, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsOsteoarthritis of the hipHip replacment surgeryMusculoskeletal - Osteoarthritis

Overview

Phase
未知
Intervention
Not specified
Conditions
Osteoarthritis of the hip
Sponsor
Royal Adelaide Hospital, Central Adelaide Local Health Network
Enrollment
130
Status
Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 19, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Royal Adelaide Hospital, Central Adelaide Local Health Network

Eligibility Criteria

Inclusion Criteria

  • •1\. Patient’s undergoing primary THA for hip osteoarthritis with BMI less than or equal to 35 kg/m2
  • •2\. Patients able to undergo the required radiological examinations.
  • •3\. Patients able to undergo gait and activity analysis safely, as deemed by the surgeon.

Exclusion Criteria

  • •1\. Patients aged more than 80 years
  • •2\. Patients with BMI greater than 35 kg/m2
  • •3\. Patients with diagnosis other than osteoarthritis
  • •4\. Other diagnosis affecting gait (eg. osteoarthritis in other joint, cerebrovascular accident, Parkinson’s disease)
  • •5\. Severely limited mobility \- cannot walk 10m for gait analysis safely unaided
  • •6\. Participants with difficulty in comprehending study protocol through written or verbal English
  • •7\. Concurrent pregnancy
  • •8\.Patients unable or unwilling to return for follow\-up
  • •9\.Other significant disorder unconducive to participation, per surgeon

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 1
Peony and licorice decoction fumigation treatment for strephenopodia after stroke: study protocol for a randomized controlled pilot trial
ITMCTR2000003253Dongzhimen Hospital affiliated to Beijing University of Chinese Medicine
Active, not recruiting
Not Applicable
Ocriplasmin for Vitreomacular Traction/Symptomatic Vitreomacular Adhesio
EUCTR2013-005464-25-NLAlcon Research, Ltd.474
Active, not recruiting
Not Applicable
Ocriplasmin for Vitreomacular Traction/Symptomatic Vitreomacular AdhesioVitreomacular Traction/ Symptomatic Vitreomacular AdhesionMedDRA version: 18.0Level: LLTClassification code 10070236Term: Vitreomacular adhesionSystem Organ Class: 100000004853MedDRA version: 18.0Level: LLTClassification code 10051065Term: Vitreomacular traction syndromeSystem Organ Class: 100000004853Therapeutic area: Diseases [C] - Eye Diseases [C11]
EUCTR2013-005464-25-FRAlcon Research, Ltd.474
Active, not recruiting
Not Applicable
Ocriplasmin for Vitreomacular Traction/Symptomatic Vitreomacular AdhesioVitreomacular Traction/ Symptomatic Vitreomacular AdhesionMedDRA version: 16.1Level: LLTClassification code 10070236Term: Vitreomacular adhesionSystem Organ Class: 100000004853MedDRA version: 16.1Level: LLTClassification code 10051065Term: Vitreomacular traction syndromeSystem Organ Class: 100000004853Therapeutic area: Diseases [C] - Eye Diseases [C11]
EUCTR2013-005464-25-ESAlcon Research, Ltd.474
Active, not recruiting
Not Applicable
Ocriplasmin for Vitreomacular Traction/Symptomatic Vitreomacular AdhesioVitreomacular Traction/ Symptomatic Vitreomacular AdhesionMedDRA version: 17.0Level: LLTClassification code 10070236Term: Vitreomacular adhesionSystem Organ Class: 100000004853MedDRA version: 17.0Level: LLTClassification code 10051065Term: Vitreomacular traction syndromeSystem Organ Class: 100000004853Therapeutic area: Diseases [C] - Eye Diseases [C11]
EUCTR2013-005464-25-PLAlcon Research, Ltd.474